Clinical trial Recruiting at 1 site Interventional Ages 19 and up

Personalized rTMS therapy to improve upper limb function in stroke patients

Official title: Efficacy of Personalized Repetitive Transcranial Magnetic Stimulation Protocol Based on Functional Reserve to Enhance Upper Limb Function in Subacute Stroke Patients: A Multi Center, Randomized, Single Blind, Parallel Group Prospective Clinical Trial

Run by Samsung Medical Center · NCT06270238 · Data updated 2026-11-12

This study is testing if personalized brain stimulation can help improve arm movement in stroke patients by tailoring the treatment to their specific needs.

Quick facts

Study typeInterventional
Ages19 Years and up
SexAll
Enrollment120 (estimated)
SponsorSamsung Medical Center
Academic / other
Locations1 site (Seoul)
StatusRecruiting
StartedFebruary 13, 2024
Main results expectedSeptember 30, 2026
Study endsSeptember 30, 2026
Registry record updatedApril 24, 2026
Trial IDNCT06270238 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are hemiplegic stroke patients in the subacute phase, aged 19 or older, with specific functional limitations.

Probably not a fit

Patients with contraindications to rTMS or those with significant coexisting neurological or psychiatric conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of personalized repetitive transcranial magnetic stimulation (rTMS) protocols tailored to the functional reserve of hemiplegic stroke patients in the subacute phase. By categorizing patients based on their corticospinal tract preservation, the study aims to compare the outcomes of individualized rTMS treatment against conventional low-frequency rTMS therapy. The approach is designed to enhance motor function recovery by addressing the unique needs of each patient rather than applying a one-size-fits-all protocol. The study involves screening evaluations, including motor evoked potentials and imaging techniques, to determine the most effective stimulation targets.

Why it matters

Potential benefit: If successful, this approach could lead to improved upper limb function and recovery outcomes for stroke patients.

How similar studies have gone: While traditional rTMS protocols have been widely studied, this personalized approach based on functional reserve is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. hemiplegic stroke patients in the subacute phase (7 days to 3 months from the onset) who are currently hospitalized,
2. FMA score of the upper extremity ≤42,
3. adequate language and cognitive function to perform at least a 1-step obey-command,
4. pre-stroke functional level of modified Rankin Scale (mRS) ≤1,
5. aged ≥19 years old,
6. patients willing to sign the informed consent.

Exclusion Criteria:

1. those with contraindications to rTMS, such as epilepsy, implanted metal objects in the head, or a history of craniotomy,
2. those with progressive of hemodynamically unstable medical conditions,
3. those with coexisting neurological conditions, such as spinal cord injury or Parkinson's disease,
4. those with major psychiatric disorders, such as major depression, schizophrenia, or dementia,
5. those having contraindications to conduct an MRI study,
6. those who are pregnant or lactating ,
7. patients who have refused to participate in this study.

Where it's running

  • Samsung Medical Center
    Seoul, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.